首页> 外文期刊>Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions >Three-dimensional printing assisted transcatheter closure of atrial septal defect with deficient posterior-inferior rim
【24h】

Three-dimensional printing assisted transcatheter closure of atrial septal defect with deficient posterior-inferior rim

机译:三维印刷辅助经截管闭合间隔缺陷,缺乏缺陷的后劣质边缘

获取原文
获取原文并翻译 | 示例
           

摘要

Objective Though successful transcatheter closure has been reported in secundum atrial septal defect (ASD) with deficient posterior-inferior rim, it is still difficult to screen the appropriate candidates. Three-dimensional printing (3DP) makes in vitro trial occlusion possible, and might provide a feasible method in the prediction of successful closure. Methods Thirty-five consecutive ASD patients (10M/25F, age, 47.7 +/- 11.8 years) with deficient posterior-inferior rim (= 3 mm) were referred for attempted transcatheter closure, and personalized heart model (elastic rubber) was produced based on end-systolic MSCT images. The in vitro measurement and trial occlusion were performed for preoperative evaluation (in vitro successful/unsuccessful group), and the results were compared with postoperative outcomes. Results Successful in vitro occlusion was achieved in 30 patients (7M/23F), and the size of ASD was 27.1 +/- 4.4 mm. The posterior-inferior rim was 0.95 +/- 1.22 mm (rim defect in 17 patients), and 12 patients were associated with aortic rim deficiency. The subsequent transcatheter closure was performed successfully in 29 patients, and the occluder-diameter was identical to that of in vitro occlusion (35.0 +/- 4.4 mm). The follow-up (1.4 +/- 0.58 years) showed no residual shunt and related-complications. In unsuccessful in vitro group (n = 5), the range of rim deficiency was wider (P = 0.019) and the rim to inferior vena cava was shorter (4.60 +/- 2.07 mm vs. 10.71 +/- 5.28 mm, P = 0.016). Furthermore, transcatheter closure failed in all patients. Conclusions In ASD with deficient posterior-inferior rim, 3DP allows accurate determination of the size and surrounding rims of ASD. Based on personalized heart model, in vitro trial occlusion is an effective method to identify the appropriate candidates for transcatheter closure.
机译:目的虽然在Secundum间隔缺陷(ASD)中报告了成功的经截面闭合,但缺乏缺陷的后缘边缘,仍然难以筛选适当的候选者。三维印刷(3DP)使体外试验闭塞可能,并且可以在预测成功封闭时提供可行的方法。方法对尝试的经截管闭合而引用了三十五名连续的ASD患者(10M / 25F,年龄,年龄,47.7 +/-11.1〜8岁),并进行个性化的心脏模型(弹性橡胶)基于终端 - 收缩系MSCT图像产生。进行术前评价(体外成功/不成功组)进行体外测量和试验闭塞,并将结果与​​术后结果进行比较。结果在30名患者(7M / 23F)中取得了成功的体外闭塞,ASD的大小为27.1 +/- 4.4mm。后劣质边缘为0.95 +/- 1.22 mm(17名患者的边缘缺陷),12名患者与主动脉缺陷有关。随后的经导管闭合在29名患者中成功进行,封闭栓剂直径与体外闭塞(35.0 +/- 4.4mm)相同。随访(1.4 +/- 0.58年)显示没有残留的分流和相关并发症。在不成功的体外组(n = 5)中,边缘缺乏的范围较宽(P = 0.019),边缘到较差的腔静脉(4.60 +/- 2.07 mm与10.71 +/- 5.28 mm,P = 0.016)。此外,在所有患者中,经截管闭合都会失败。随着缺陷的后劣质边缘的结论,3DP允许精确确定ASD的尺寸和周围边缘。基于个性化心脏模型,体外试验闭塞是鉴定经截面闭合的适当候选者的有效方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号